Parenchymal lung lesions in Hodgkin[scquote]s disease resistant to chemotherapy

A. E. Skrahin, P. B. Mitskevich, S. V. Vlasenkova, A. M. Skrahina (Minsk, Belarus)

Source: Annual Congress 2002 - Thoracic oncology: rare tumours and metastases
Session: Thoracic oncology: rare tumours and metastases
Session type: Thematic Poster Session
Number: 2954
Disease area: Respiratory infections, Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. E. Skrahin, P. B. Mitskevich, S. V. Vlasenkova, A. M. Skrahina (Minsk, Belarus). Parenchymal lung lesions in Hodgkin[scquote]s disease resistant to chemotherapy. Eur Respir J 2002; 20: Suppl. 38, 2954

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
A study on chemotherapy induced interstitial lung disease in patients with unresectable non-small cell lung cancer complicated by combined pulmonary fibrosis and emphysema
Source: Annual Congress 2012 - Treatment of lung cancer
Year: 2012


Carboplatin and paclitaxel chemotherapy for lung cancer patients with interstitial lung disease
Source: Annual Congress 2010 - Treatment of lung cancer
Year: 2010

Toxicity in isolated lung perfusion with melphalan for resectable lung metastases
Source: Annual Congress 2006 - Contemporary issues in thoracic surgical oncology
Year: 2006


Mild parenchymal lung disease is still lung disease
Source: Eur Respir J, 56 (5) 2003542; 10.1183/13993003.03542-2020
Year: 2020



Mild parenchymal lung disease is still lung disease
Source: Eur Respir J, 56 (5) 2003727; 10.1183/13993003.03727-2020
Year: 2020



Combination chemotherapy with gemcitabine using isolated lung perfusion for the treatment of lung metastases
Source: Eur Respir J 2004; 24: Suppl. 48, 42s
Year: 2004

Clinical characteristic of lung cancer patients with interstitial pneumonia treated with chemotherapy or radiotherapy
Source: Annual Congress 2008 - Therapy of thoracic tumours
Year: 2008


Diffuse parenchymal lung disease
Source: International Congress 2016 – Clinical year in review
Year: 2016


Diffuse parenchymal lung disease
Source: Eur Respir Rev, 26 (144) 170004; 10.1183/16000617.0004-2017
Year: 2017



Temozolomide in the treatment of brain metastases in lung cancer patients
Source: Eur Respir J 2003; 22: Suppl. 45, 65s
Year: 2003

Surgical treatment of patients with disseminated destructive multidrug resistant lung tuberculosis
Source: Eur Respir J 2005; 26: Suppl. 49, 489s
Year: 2005

Lung resistance-related protein in lung cancer and lung lesions in Hodgkin disease
Source: Eur Respir J 2006; 28: Suppl. 50, 86s
Year: 2006

Resistance to chemotherapy in lung cancer
Source: International Congress 2015 – Resistance to therapy in lung cancer
Year: 2015



Update on diffuse parenchymal lung disease
Source: Eur Respir Rev 2009; 19: 97-108
Year: 2010


Endobronchial intratumoral chemotherapy followed by surgery in early non-small-cell lung cancer with polypoid growth erroneously diagnosed as an advanced disease
Source: Eur Respir J 2006; 28: Suppl. 50, 610s
Year: 2006

Early detection of subclinical interstitial lung disease in patients with rheumatoid arthritis and effect of methotrexate therapy
Source: International Congress 2014 – ILDs 4
Year: 2014

Severe fibrotic lung disease – How much therapy is too much therapy?
Source: Annual Congress 2008 - Clinical Grand Round - an interactive session
Year: 2008


A retrospective study of lung parenchymal damage after neoadjuvant chemo and radiotherapy for non small cell lung cancer
Source: Eur Respir J 2002; 20: Suppl. 38, 464s
Year: 2002

Benign bone tumors as a primary foci of pulmonary metastatic disease
Source: Annual Congress 2007 - New developments in thoracic imaging modalities and illustrated thorax pathologies
Year: 2007


Second-line treatment patients at relapse of disseminated small cell lung cancer
Source: Eur Respir J 2001; 18: Suppl. 33, 395s
Year: 2001